Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05384860 · ClinicalTrials.gov registry record · NA

Incorporating Acupuncture Into ERAS for Ambulatory Total Hip Replacement (THR) Surgery

A NA study of Opioid Use and Acupuncture, sponsored by Hospital for Special Surgery, New York.

Completed
Registry status
NA
Development phase
484
Enrollment target
1
Study location

NCT05384860: Completed NA study of Opioid Use and Acupuncture, sponsored by Hospital for Special Surgery, New York.

NCT05384860 is a NA study of Opioid Use and Acupuncture that has completed, run by Hospital for Special Surgery, New York. The registered enrollment target is 484 participants, below the 148,255-participant average among 105 other Opioid Use trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05384860, a NA study of Opioid Use and Acupuncture, has completed, sponsored by Hospital for Special Surgery, New York.

COMPLETED
Registry status
NA
Development phase
484 participants
Enrollment target
1
Study location

Study Summary

At this time, no formal ERAS (enhanced recovery after surgery) protocol exists for THR that incorporates perioperative acupuncture. Developing, and more importantly, validating a preliminary fast-track protocol for THR can have a significant impact on reducing recovery time and improving the rate at which this subgroup of surgeries is done on an outpatient basis. Furthermore, previous studies of acupuncture as an adjunctive therapy for postoperative analgesia have primarily investigated patient satisfaction rather than the impact on postoperative opioid consumption. The majority of studies also place acupuncture needles preoperatively, rather than following induction of anesthesia (intra-operatively). This study hopes to show that placing auricular therapy needles intraoperatively is a feasible part of a protocol for motivated patients to minimize opioids after total knee arthroplasty. The prospect of incorporating intraoperative acupuncture as an adjunct into said protocol is very attractive given its low cost, its safety profile, its ease of administration, and the growing evidence supporting its efficacy. This study would provide further clarity on whether perioperative acupuncture can effectively reduce hospital length of stay and post-operative opioid consumption, in addition to evaluating the role of perioperative acupuncture in improving recovery after THR as part of a multimodal fast-track protocol.

Primary Outcome

The primary outcome is the incidence of patients who maintain a low-dose opioid regimen (71.5 OME or less) out to 30 days post-op. Patient intake of opioid medication will be measured up to the 30 days post-operation.

Interventions

  • DEVICE Auricular Trauma Protocol (ATP) Acupuncture
  • OTHER No Acupuncture Group

Study Locations (1)

New York

  • Hospital for Special Surgery - New York

Trial Details

FieldValue
Enrollment Target 484 participants
Start Date 2022-07-06
Est. Completion 2025-04-04
Phase NA

What the finished NCT05384860 record still lists

NCT05384860 is an interventional study that assigns participants to a tested intervention. The registered 484 participants enrollment target is mid-sized for trials with a published cap, below the 148,255-participant average among 105 other Opioid Use trials with a reported enrollment target (100% lower).

The record links to 3 conditions, with Opioid Use appearing as the primary indexed condition, and to 2 interventions - of which Auricular Trauma Protocol (ATP) Acupuncture is the first listed.

NCT05384860 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT05384860 about?

NCT05384860 is a clinical study titled "Incorporating Acupuncture Into ERAS for Ambulatory Total Hip Replacement (THR) Surgery". At this time, no formal ERAS (enhanced recovery after surgery) protocol exists for THR that incorporates perioperative acupuncture. Developing, and more importantly, validating a preliminary fast-track protocol for THR can have a significant impact on reducing recovery time and improving the rate at...

What is the current status of trial NCT05384860?

This trial is currently completed. It is a NA study. The enrollment target is 484 participants. The study started on 2022-07-06. Estimated completion is 2025-04-04.

What conditions does trial NCT05384860 study?

This clinical trial studies the following conditions: Opioid Use, Acupuncture, Hip Surgery.

What interventions are being tested in trial NCT05384860?

The interventions under investigation include: Auricular Trauma Protocol (ATP) Acupuncture (DEVICE), No Acupuncture Group (OTHER).

Who is sponsoring clinical trial NCT05384860?

This trial is sponsored by Hospital for Special Surgery, New York, which has 194 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05384860 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Opioid Use

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05384860's enrollment target sits among peer trials

484 20th of 105 higher than 86 of 105 other Opioid Use trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Opioid Use trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05421741 · 484 participants · Phase 4

    Prophylactic Antibiotic Coated Nail to Prevent Infection: A Clinical Trial

  • NCT07124910 · 485 participants · Phase 3

    Comparison of Epi-ON Corneal Collagen Crosslinking Performed Using an 18-Minute UVA Exposure vs. a 24-Minute UVA Exposure on Eyes With Ectatic Corneal Diseases

  • NCT02871726 · 483 participants · NA

    Transrectal Ultrasound Robot-Assisted Prostate Biopsy

  • NCT06420531 · 486 participants · NA

    Milk And Growth In Children (MAGIC) Born Very Preterm: A Randomized Trial

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05384860, the US trial registry maintained by the National Library of Medicine. NCT05384860 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.